Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC.
Sandra HuberConstance BaerStephan HutterFrank DickerIrene FuhrmannManja MeggendorferChristian PohlkampWolfgang KernTorsten HaferlachClaudia HaferlachGregor HoermannPublished in: Leukemia (2023)